Drug Profile
Research programme: non-hormonal female sexual dysfunction therapeutics - Intra-Cellular Therapies
Alternative Names: ITI-003Latest Information Update: 08 Apr 2014
Price :
$50
*
At a glance
- Originator Intra-Cellular Therapies
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Female sexual dysfunction
Most Recent Events
- 18 Sep 2007 Preclinical trials in Female sexual dysfunction in USA (unspecified route)